000 01409 a2200385 4500
005 20250515232928.0
264 0 _c20101206
008 201012s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2010.06.126
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnselm, Lilli
245 0 0 _aDiscovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cSep 2010
300 _a5313-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aFactor Xa Inhibitors
650 0 4 _aPyrrolidines
_xchemistry
700 1 _aBanner, David W
700 1 _aBenz, Jörg
700 1 _aZbinden, Katrin Groebke
700 1 _aHimber, Jacques
700 1 _aHilpert, Hans
700 1 _aHuber, Walter
700 1 _aKuhn, Bernd
700 1 _aMary, Jean-Luc
700 1 _aOtteneder, Michael B
700 1 _aPanday, Narendra
700 1 _aRicklin, Fabienne
700 1 _aStahl, Martin
700 1 _aThomi, Stefan
700 1 _aHaap, Wolfgang
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 20
_gno. 17
_gp. 5313-9
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2010.06.126
_zAvailable from publisher's website
999 _c19991372
_d19991372